Frazier Life Sciences Management, L.P.
Position in ACAD — Acadia Pharmaceuticals Inc
CIK 1892134
PALO ALTO, CA
Position in ACAD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$32,014,287
-$2,633,871 QoQ
Shares Held
1,438,198
+10.9% QoQ
Ownership
0.840%
of shares outstanding
% of Portfolio
0.83%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2022
14 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ACAD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Frazier Life Sciences Management, L.P. holds $3,802,745,091 across 34 Biotechnology names. ACAD ranks #23 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MIRM |
Mirum Pharmaceuticals, Inc.
|
7,679,684 | $709,449,207 | |
| 2 | NAMS |
NewAmsterdam Pharma Co N.V.
|
16,943,774 | $542,370,205 | |
| 3 | ERAS |
Erasca, Inc.
|
24,675,188 | $399,244,541 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
3,448,139 | $256,058,802 | |
| 5 | ARQT |
Arcutis Biotherapeutics, Inc.
|
9,874,511 | $232,643,479 | |
| 6 | MBX |
MBX Biosciences, Inc.
|
6,652,013 | $198,562,588 | |
| 7 | PHAT |
Phathom Pharmaceuticals, Inc.
|
12,466,489 | $138,502,692 | |
| 8 | MAZE |
Maze Therapeutics, Inc.
|
4,567,274 | $136,333,128 |
All Filings in ACAD
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $32,014,287 | 1,438,198 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $34,648,158 | 1,297,198 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $13,099,281 | 613,837 | Shares | Sole | 2025-11-14 | |
| 2025-03-31 | $7,812,314 | 470,338 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $8,630,702 | 470,338 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $7,233,798 | 470,338 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $7,642,992 | 470,338 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $8,696,549 | 470,338 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $22,885,011 | 730,917 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $13,147,893 | 630,897 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $20,533,245 | 857,338 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $16,135,101 | 857,338 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $13,648,820 | 857,338 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $14,026,049 | 857,338 | Shares | Sole | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||